Genexis Group presents Q2 2024 financial report
Genexis Group’s net consolidated sales YTD Q2 2024 were EUR 36.8 million, slightly down by EUR 2.3 million from YTD Q2 2023.The consolidated adjusted EBITDA for YTD Q2 was EUR 5.2 million (EUR 5.0 million YTD Q2 2023), and the operating cash flow after investment activities was EUR -1.5 million (EUR -6.9 million). We continue to focus efforts on lowering Operating Expenses and took further actions during Q2, optimizing the company for the shift towards product and solutions sales. Further cost synergies are expected to be realized over the year. “Q2 2024 has been disappointing in